| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.518 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.480 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.364 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.329 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.290 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 44 | 0.282 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.272 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.269 | Mouse |
| regulation of proteolysis | GO:0030162 | 293 | 0.258 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.247 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.242 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.241 | Mouse |
| histone acetylation | GO:0016573 | 93 | 0.241 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.226 | Mouse |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.224 | |
| protein processing | GO:0016485 | 226 | 0.221 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.215 | |
| post embryonic development | GO:0009791 | 2 | 0.210 | |
| protein localization to organelle | GO:0033365 | 280 | 0.199 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.195 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.192 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.188 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.179 | Mouse |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.168 | |
| secretion | GO:0046903 | 254 | 0.168 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.165 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.163 | |
| locomotory behavior | GO:0007626 | 1 | 0.154 | |
| response to other organism | GO:0051707 | 261 | 0.149 | Mouse |
| positive regulation of immune response | GO:0050778 | 159 | 0.146 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.143 | |
| defense response | GO:0006952 | 315 | 0.140 | |
| protein catabolic process | GO:0030163 | 325 | 0.136 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.133 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.124 | |
| actin filament based process | GO:0030029 | 224 | 0.122 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.121 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.117 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.116 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.114 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 72 | 0.114 | |
| signal transduction in response to dna damage | GO:0042770 | 57 | 0.110 | |
| endomembrane system organization | GO:0010256 | 196 | 0.110 | |
| protein maturation | GO:0051604 | 233 | 0.107 | |
| detection of muramyl dipeptide | GO:0032498 | 1 | 0.107 | |
| protein acylation | GO:0043543 | 138 | 0.105 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.104 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.101 | |
| protein import into nucleus | GO:0006606 | 104 | 0.101 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.096 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.096 | |
| dna packaging | GO:0006323 | 77 | 0.093 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.092 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.092 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.091 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.091 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.090 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.089 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.089 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.088 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.086 | |
| positive regulation of transport | GO:0051050 | 336 | 0.086 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.086 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.084 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.084 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.083 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.083 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.083 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.082 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.082 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.081 | |
| signal transduction by p53 class mediator | GO:0072331 | 72 | 0.081 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.081 | |
| protein import | GO:0017038 | 130 | 0.080 | |
| single organism cellular localization | GO:1902580 | 332 | 0.077 | |
| secretion by cell | GO:0032940 | 226 | 0.077 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 78 | 0.077 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.077 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.077 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.075 | |
| regulation of immune response | GO:0050776 | 201 | 0.074 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.074 | |
| segmentation | GO:0035282 | 4 | 0.073 | |
| dna repair | GO:0006281 | 198 | 0.073 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 156 | 0.073 | |
| regulation of defense response | GO:0031347 | 154 | 0.072 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.072 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.072 | |
| oogenesis | GO:0048477 | 2 | 0.072 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.071 | |
| protein targeting to nucleus | GO:0044744 | 104 | 0.071 | |
| immune response | GO:0006955 | 307 | 0.070 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.070 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.069 | |
| regulation of protein processing | GO:0070613 | 150 | 0.068 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.068 | |
| regulation of innate immune response | GO:0045088 | 97 | 0.066 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.066 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.065 | Mouse |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.065 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.065 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.065 | |
| intracellular protein transport | GO:0006886 | 270 | 0.064 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.064 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.064 | |
| histone h3 acetylation | GO:0043966 | 45 | 0.063 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.061 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.060 | |
| protein oligomerization | GO:0051259 | 173 | 0.060 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.059 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.058 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.057 | |
| membrane organization | GO:0061024 | 292 | 0.057 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.056 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.056 | Mouse |
| rna processing | GO:0006396 | 255 | 0.056 | |
| release of cytoplasmic sequestered nf kappab | GO:0008588 | 4 | 0.056 | |
| regulation of protein maturation | GO:1903317 | 150 | 0.056 | |
| single organism membrane organization | GO:0044802 | 268 | 0.055 | |
| regulation of signal transduction by p53 class mediator | GO:1901796 | 26 | 0.054 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.054 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.054 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.054 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.053 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.053 | |
| regulation of chromatin organization | GO:1902275 | 56 | 0.052 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.051 | |
| innate immune response | GO:0045087 | 178 | 0.050 | |
| gtp catabolic process | GO:0006184 | 237 | 0.050 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.049 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.049 | |
| cell cycle g1 s phase transition | GO:0044843 | 80 | 0.048 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.048 | |
| single organism nuclear import | GO:1902593 | 104 | 0.048 | |
| organelle assembly | GO:0070925 | 176 | 0.047 | |
| striated muscle contraction | GO:0006941 | 52 | 0.047 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.047 | |
| nuclear import | GO:0051170 | 106 | 0.047 | |
| protein ubiquitination | GO:0016567 | 314 | 0.046 | |
| negative regulation of cellular catabolic process | GO:0031330 | 83 | 0.046 | |
| gtp metabolic process | GO:0046039 | 239 | 0.045 | |
| negative regulation of cell cycle g1 s phase transition | GO:1902807 | 29 | 0.045 | |
| maintenance of location | GO:0051235 | 112 | 0.045 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.045 | |
| protein homooligomerization | GO:0051260 | 100 | 0.044 | |
| regulation of protein transport | GO:0051223 | 213 | 0.044 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.044 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.044 | |
| protein secretion | GO:0009306 | 98 | 0.043 | |
| regulation of growth | GO:0040008 | 165 | 0.043 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.043 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.043 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.042 | |
| protein targeting | GO:0006605 | 187 | 0.042 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.041 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.041 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.041 | |
| taxis | GO:0042330 | 157 | 0.041 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.041 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.040 | |
| mitochondrion organization | GO:0007005 | 156 | 0.040 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.040 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 91 | 0.039 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.039 | |
| histone modification | GO:0016570 | 251 | 0.039 | |
| mitotic dna damage checkpoint | GO:0044773 | 28 | 0.039 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.039 | |
| histone h2a phosphorylation | GO:1990164 | 3 | 0.039 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.039 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.039 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.038 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.038 | |
| response to oxidative stress | GO:0006979 | 121 | 0.038 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.038 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.038 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.038 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.038 | |
| regulation of protein targeting | GO:1903533 | 91 | 0.038 | |
| oocyte development | GO:0048599 | 1 | 0.037 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.037 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.037 | |
| intracellular mrna localization | GO:0008298 | 1 | 0.037 | |
| chromatin modification | GO:0016568 | 298 | 0.036 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.036 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.036 | |
| response to growth factor | GO:0070848 | 205 | 0.036 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.035 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.035 | |
| maintenance of protein location | GO:0045185 | 57 | 0.035 | |
| response to bacterium | GO:0009617 | 144 | 0.034 | Mouse |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.034 | |
| regulation of protein localization | GO:0032880 | 296 | 0.034 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.033 | |
| cell cycle arrest | GO:0007050 | 71 | 0.033 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.033 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 3 | 0.033 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 37 | 0.032 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.032 | |
| endosomal transport | GO:0016197 | 129 | 0.032 | |
| cell cycle checkpoint | GO:0000075 | 117 | 0.032 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.032 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.032 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.031 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.031 | |
| protein acetylation | GO:0006473 | 116 | 0.031 | |
| regulation of protein import into nucleus | GO:0042306 | 78 | 0.031 | |
| lipid metabolic process | GO:0006629 | 381 | 0.031 | |
| negative regulation of protein processing | GO:0010955 | 142 | 0.031 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.031 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.030 | |
| female gamete generation | GO:0007292 | 2 | 0.030 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.030 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.030 | |
| endocytosis | GO:0006897 | 159 | 0.030 | |
| chromatin assembly | GO:0031497 | 61 | 0.030 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.030 | |
| negative regulation of protein catabolic process | GO:0042177 | 59 | 0.030 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.030 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.029 | |
| detection of stimulus | GO:0051606 | 85 | 0.029 | |
| activation of immune response | GO:0002253 | 114 | 0.029 | |
| response to fungus | GO:0009620 | 4 | 0.029 | |
| negative regulation of catabolic process | GO:0009895 | 104 | 0.029 | |
| atp catabolic process | GO:0006200 | 157 | 0.029 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.029 | |
| defense response to other organism | GO:0098542 | 129 | 0.029 | |
| regulation of protein localization to nucleus | GO:1900180 | 85 | 0.029 | |
| translation | GO:0006412 | 132 | 0.028 | |
| g1 dna damage checkpoint | GO:0044783 | 18 | 0.028 | |
| dna templated transcription initiation | GO:0006352 | 35 | 0.028 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.028 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.028 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.028 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.028 | |
| positive regulation of defense response | GO:0031349 | 87 | 0.027 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 38 | 0.027 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.027 | |
| muscle tissue development | GO:0060537 | 62 | 0.027 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.027 | |
| apoptotic mitochondrial changes | GO:0008637 | 57 | 0.027 | |
| oocyte differentiation | GO:0009994 | 2 | 0.027 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.027 | |
| meiotic chromosome segregation | GO:0045132 | 4 | 0.027 | |
| behavior | GO:0007610 | 112 | 0.027 | |
| protein modification by small protein removal | GO:0070646 | 92 | 0.026 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.026 | |
| dna conformation change | GO:0071103 | 113 | 0.026 | |
| mitotic dna integrity checkpoint | GO:0044774 | 30 | 0.026 | |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.026 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.026 | |
| regulation of rho protein signal transduction | GO:0035023 | 79 | 0.026 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.026 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.026 | |
| memory | GO:0007613 | 3 | 0.026 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 159 | 0.025 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.025 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 158 | 0.025 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.025 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 40 | 0.025 | |
| dna integrity checkpoint | GO:0031570 | 71 | 0.025 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.025 | |
| regulation of cellular protein catabolic process | GO:1903362 | 96 | 0.025 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.025 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.025 | |
| regulation of cell growth | GO:0001558 | 135 | 0.025 | |
| lipid catabolic process | GO:0016042 | 84 | 0.025 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.025 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.025 | |
| microtubule based process | GO:0007017 | 210 | 0.024 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.024 | |
| nuclear transport | GO:0051169 | 179 | 0.024 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.024 | |
| cellular response to extracellular stimulus | GO:0031668 | 72 | 0.024 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.024 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.024 | |
| epithelial cell migration | GO:0010631 | 119 | 0.024 | |
| maintenance of protein location in cell | GO:0032507 | 56 | 0.024 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.024 | |
| response to starvation | GO:0042594 | 59 | 0.024 | |
| negative regulation of growth | GO:0045926 | 97 | 0.023 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.023 | |
| negative regulation of transport | GO:0051051 | 176 | 0.023 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 191 | 0.023 | |
| cell morphogenesis | GO:0000902 | 296 | 0.023 | |
| myosin filament assembly | GO:0031034 | 2 | 0.023 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.023 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.023 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.023 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.022 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.022 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.022 | |
| regulation of cell motility | GO:2000145 | 299 | 0.022 | |
| tripartite regional subdivision | GO:0007351 | 2 | 0.022 | |
| regulation of cell migration | GO:0030334 | 289 | 0.022 | |
| cell growth | GO:0016049 | 160 | 0.022 | |
| amine metabolic process | GO:0009308 | 44 | 0.022 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.022 | |
| response to virus | GO:0009615 | 126 | 0.022 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.022 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.022 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.022 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.022 | |
| hindlimb morphogenesis | GO:0035137 | 2 | 0.022 | |
| tissue migration | GO:0090130 | 119 | 0.021 | |
| negative regulation of chromosome organization | GO:2001251 | 48 | 0.021 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.021 | |
| immune effector process | GO:0002252 | 159 | 0.021 | |
| regulation of locomotion | GO:0040012 | 329 | 0.021 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.021 | |
| system process | GO:0003008 | 349 | 0.021 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 29 | 0.021 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.021 | |
| detection of chemical stimulus | GO:0009593 | 55 | 0.021 | |
| meiosis i | GO:0007127 | 4 | 0.021 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.021 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.021 | |
| activation of innate immune response | GO:0002218 | 55 | 0.021 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 87 | 0.020 | |
| regeneration | GO:0031099 | 4 | 0.020 | |
| macroautophagy | GO:0016236 | 39 | 0.020 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.020 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 41 | 0.020 | Mouse |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.020 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.020 | |
| double strand break repair | GO:0006302 | 101 | 0.020 | |
| response to glucagon | GO:0033762 | 1 | 0.020 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.020 | |
| establishment of protein localization to membrane | GO:0090150 | 121 | 0.020 | |
| regulation of immune effector process | GO:0002697 | 91 | 0.020 | |
| response to insulin | GO:0032868 | 45 | 0.020 | |
| positive regulation of response to dna damage stimulus | GO:2001022 | 43 | 0.020 | |
| histone h4 acetylation | GO:0043967 | 47 | 0.019 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.019 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.019 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.019 | |
| chromosome segregation | GO:0007059 | 114 | 0.019 | |
| cellular response to radiation | GO:0071478 | 65 | 0.019 | |
| negative regulation of response to wounding | GO:1903035 | 47 | 0.019 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.019 | |
| cell development | GO:0048468 | 328 | 0.019 | |
| regulation of inflammatory response | GO:0050727 | 46 | 0.018 | |
| inflammatory response | GO:0006954 | 79 | 0.018 | |
| neurological system process | GO:0050877 | 163 | 0.018 | |
| regulation of antimicrobial humoral response | GO:0002759 | 1 | 0.018 | |
| transcription initiation from rna polymerase ii promoter | GO:0006367 | 27 | 0.018 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.018 | |
| circadian sleep wake cycle sleep | GO:0050802 | 2 | 0.018 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.018 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.018 | |
| cell projection organization | GO:0030030 | 252 | 0.018 | |
| rhythmic behavior | GO:0007622 | 2 | 0.018 | |
| actin filament organization | GO:0007015 | 128 | 0.018 | |
| positive regulation of rho protein signal transduction | GO:0035025 | 4 | 0.018 | |
| muscle structure development | GO:0061061 | 98 | 0.018 | |
| chromatin organization | GO:0006325 | 351 | 0.018 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.018 | |
| epithelium migration | GO:0090132 | 119 | 0.018 | |
| autophagy | GO:0006914 | 88 | 0.018 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.018 | |
| regulation of synaptic transmission dopaminergic | GO:0032225 | 4 | 0.018 | |
| regulation of protein stability | GO:0031647 | 87 | 0.018 | |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.018 | |
| positive regulation of protein catabolic process | GO:0045732 | 75 | 0.018 | |
| mitotic nuclear division | GO:0007067 | 119 | 0.018 | |
| nuclear division | GO:0000280 | 128 | 0.018 | |
| cytokine production | GO:0001816 | 247 | 0.017 | |
| response to nutrient levels | GO:0031667 | 81 | 0.017 | |
| vesicle organization | GO:0016050 | 62 | 0.017 | |
| blastocyst development | GO:0001824 | 3 | 0.017 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.017 | |
| regulation of cell development | GO:0060284 | 161 | 0.017 | |
| regulation of translation | GO:0006417 | 89 | 0.017 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.017 | |
| regulation of secretion | GO:0051046 | 194 | 0.017 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.017 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.017 | |
| protein stabilization | GO:0050821 | 64 | 0.017 | |
| cardiovascular system development | GO:0072358 | 262 | 0.017 | |
| interleukin 1 secretion | GO:0050701 | 18 | 0.017 | |
| response to lipid | GO:0033993 | 206 | 0.017 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.017 | |
| biological adhesion | GO:0022610 | 331 | 0.017 | |
| nucleosome assembly | GO:0006334 | 50 | 0.017 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.017 | |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.017 | |
| cellular response to starvation | GO:0009267 | 58 | 0.016 | |
| glycosylation | GO:0070085 | 71 | 0.016 | |
| maintenance of location in cell | GO:0051651 | 62 | 0.016 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.016 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.016 | |
| mrna processing | GO:0006397 | 133 | 0.016 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.016 | |
| zymogen activation | GO:0031638 | 70 | 0.016 | |
| cell adhesion | GO:0007155 | 325 | 0.016 | |
| skeletal muscle tissue growth | GO:0048630 | 2 | 0.016 | |
| humoral immune response | GO:0006959 | 49 | 0.016 | |
| dephosphorylation | GO:0016311 | 209 | 0.016 | |
| cell aging | GO:0007569 | 52 | 0.016 | |
| cardiac muscle cell contraction | GO:0086003 | 4 | 0.016 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.016 | |
| positive regulation of protein localization to nucleus | GO:1900182 | 48 | 0.016 | |
| leukocyte chemotaxis | GO:0030595 | 76 | 0.016 | |
| defense response to fungus | GO:0050832 | 4 | 0.016 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.016 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.016 | |
| regulation of release of cytochrome c from mitochondria | GO:0090199 | 29 | 0.016 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.016 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.016 | |
| regulation of meiosis | GO:0040020 | 3 | 0.016 | |
| response to uv | GO:0009411 | 73 | 0.016 | |
| innate immune response activating signal transduction | GO:0002758 | 48 | 0.016 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 2 | 0.015 | |
| cardiac muscle contraction | GO:0060048 | 34 | 0.015 | |
| chromosome separation | GO:0051304 | 23 | 0.015 | |
| retrograde transport endosome to golgi | GO:0042147 | 45 | 0.015 | |
| chemotaxis | GO:0006935 | 157 | 0.015 | |
| vacuole organization | GO:0007033 | 44 | 0.015 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.015 | |
| positive regulation of nf kappab transcription factor activity | GO:0051092 | 81 | 0.015 | |
| response to molecule of bacterial origin | GO:0002237 | 82 | 0.015 | |
| anterior posterior axis specification embryo | GO:0008595 | 2 | 0.015 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 54 | 0.015 | |
| cell matrix adhesion | GO:0007160 | 85 | 0.015 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.015 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.015 | |
| hormone metabolic process | GO:0042445 | 61 | 0.015 | |
| response to testosterone | GO:0033574 | 1 | 0.015 | |
| negative regulation of proteolysis involved in cellular protein catabolic process | GO:1903051 | 35 | 0.015 | |
| oxidation reduction process | GO:0055114 | 396 | 0.015 | |
| organophosphate biosynthetic process | GO:0090407 | 163 | 0.015 | |
| positive regulation of chromatin modification | GO:1903310 | 30 | 0.015 | |
| androgen biosynthetic process | GO:0006702 | 3 | 0.015 | |
| myoblast fusion | GO:0007520 | 1 | 0.015 | |
| peptide transport | GO:0015833 | 74 | 0.015 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.015 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 49 | 0.015 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.015 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 102 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.015 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 3 | 0.015 | |
| response to radiation | GO:0009314 | 151 | 0.014 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.014 | |
| steroid metabolic process | GO:0008202 | 94 | 0.014 | |
| muscle system process | GO:0003012 | 81 | 0.014 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.014 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 60 | 0.014 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 186 | 0.014 | |
| vitamin d receptor signaling pathway | GO:0070561 | 4 | 0.014 | |
| negative regulation of peptidase activity | GO:0010466 | 91 | 0.014 | |
| dna dependent dna replication | GO:0006261 | 44 | 0.014 | |
| cellular response to nutrient levels | GO:0031669 | 69 | 0.014 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.014 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.014 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.014 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.014 | |
| nucleus organization | GO:0006997 | 28 | 0.014 | |
| negative regulation of secretion by cell | GO:1903531 | 52 | 0.013 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.013 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.013 | |
| mating | GO:0007618 | 1 | 0.013 | |
| vacuolar transport | GO:0007034 | 34 | 0.013 | |
| methylation | GO:0032259 | 106 | 0.013 | |
| genetic imprinting | GO:0071514 | 1 | 0.013 | |
| lysosomal transport | GO:0007041 | 33 | 0.013 | |
| lipid localization | GO:0010876 | 106 | 0.013 | |
| circadian behavior | GO:0048512 | 2 | 0.013 | |
| stress fiber assembly | GO:0043149 | 40 | 0.013 | |
| macromolecule glycosylation | GO:0043413 | 63 | 0.013 | |
| nucleotide excision repair | GO:0006289 | 31 | 0.013 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 158 | 0.013 | |
| sleep | GO:0030431 | 2 | 0.013 | |
